Phathom Pharmaceuticals, Inc. PHAT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s total current assets?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total current assets of $276.57M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total current assets increased by 4.4% year-over-year, from $264.9M to $276.57M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total current assets has grown at a -4.7% compound annual growth rate (CAGR), from $291.37M to $228.97M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.